Christensen, Mikkel B. http://orcid.org/0000-0002-8774-1797
Jimenez-Solem, Espen
Ernst, Martin. T.
Schmidt, Morten
Pottegård, Anton
Grove, Erik L. http://orcid.org/0000-0002-1466-0865
Article History
Received: 17 January 2021
Accepted: 18 June 2021
First Online: 30 June 2021
Competing interests
: All authors have completed the ICMJE uniform disclosure form at ExternalRef removed and declare: no support from any organisation for the submitted work. Authors MC, EJS, and MTE have no conflicts of interest in relation to this manuscript. Author MS reports grant from Novo Nordisk Foundation, outside the submitted work (NNF19OC0054908). Author AP reports participation in research projects funded by Alcon, Almirall, Astellas, Astra-Zeneca, Boehringer-Ingelheim, Novo Nordisk, Servier and LEO Pharma, all with funds paid to the institution where he was employed (no personal fees) and with no relation to the work reported in this paper. Outside this manuscript, ELG has received speaker honoraria or consultancy fees from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, MSD, Lundbeck Pharma, MundiPharma, Portola Pharmaceuticals and Roche. HELG is an investigator in the SATELLITE, FLAVOUR and ETESIAN studies (AstraZeneca) and has received research grants from Boehringer Ingelheim.